Progranulin (GP88) tumor tissue expression is associated with increased risk of recurrence in breast cancer patients diagnosed with estrogen receptor positive invasive ductal carcinoma
Ginette Serrero, Douglas M. Hawkins, Binbin Yue, Olga Ioffe, Pablo Bejarano, Jeffrey T. Phillips, Jonathan F. Head, Robert L. Elliott, Katherine R. Tkaczuk, Andrew K. Godwin, Jo Ellen Weaver, Wes E. Kim
Fingerprint
Dive into the research topics of 'Progranulin (GP88) tumor tissue expression is associated with increased risk of recurrence in breast cancer patients diagnosed with estrogen receptor positive invasive ductal carcinoma'. Together they form a unique fingerprint.